MedPath

FLOVENT INHALERS-AEM INH-ORL 50MCG/ACTUATION

FLOVENT INHALERS-AEM INH-ORL 50MCG/ACTUATION

Discontinued
DIN Number

02174758

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

glaxo canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02174758
AIG Number0124685001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA05 FLUTICASONE
Product Specifications
Dosage FormMetered-Dose Aerosol
Route of AdministrationOral ,  Inhalation
AHFS Classification68:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLUTICASONE PROPIONATEActive
Strength: 50 MCG / ACT
Monograph: FLUTICASONE PROPIONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.